Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM1 | P23921 | 5/20 | 1.00 |
| ▸ | IDO1 | P14902 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 7/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.70 |
| ▸ | NPC1 | O15118 | 6/20 | 0.70 |
| ▸ | RAB9A | P51151 | 6/20 | 0.69 |
| ▸ | PPARG | P37231 | 1/20 | 0.68 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.67 |
| ▸ | KLF5 | Q13887 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | MITF | O75030 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1637575 | 1.00 | RRM1 (1.00) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL4454258 | 1.00 | RRM1 (1.00) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL1637574 | 1.00 | RRM1 (1.00) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL18963239 | 0.88 | RRM1 (1.00) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL1639477 | 0.87 | RRM1 (0.77) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL1639479 | 0.87 | RRM1 (0.77) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL12766750 | 0.87 | RRM1 (0.77) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL683715 | 0.85 | MEN1 (0.85) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL2847708 | 0.85 | MEN1 (0.85) | RRM1IDO1MEN1KMT2ANPC1 | |
| SCHEMBL7602938 | 0.84 | RRM1 (0.72) | RRM1IDO1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637832-A1 | CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A DRUG | Tubulis GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| US-20240269313-A1 | CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A DRUG | TUBULIS GMBH (DE) | 2024-08-15 | — | — | US | claimed |
| WO-2024133845-A1 | CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A DRUG | TUBULIS GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| CN-116863729-A | Multi-agent road traffic signal control method based on deep reinforcement learning algorithm | 大连交通大学 | 2023-10-10 | — | — | CN | claimed |
| EP-4637832-A1 | CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A DRUG | Tubulis GmbH (DE) | 2025-10-29 | — | — | EP | disclosed |
| US-20250250336-A1 | NOVEL LILRB4 ANTIBODIES AND USES THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-08-07 | — | — | US | disclosed |
| CN-120053428-A | Application of Zanthoxylum bungeanum toxin in preparing medicine for treating non-alcoholic fatty liver disease | 济宁医学院 | 2025-05-30 | — | — | CN | disclosed |
| CN-119529092-A | Anti-ACVR 2A antibodies and uses thereof | 来凯医药科技(上海)有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119350394-A | Phthalazinone compound, preparation method thereof, pharmaceutical composition and application | 中国药科大学 | 2025-01-24 | — | — | CN | disclosed |
| US-12202895-B2 | LILRB4 antibodies and uses thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-01-21 | — | — | US | disclosed |
| US-20250002490-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL LTD (CN) | 2025-01-02 | — | — | US | disclosed |
| CN-118955358-A | FXR partial agonist containing piperidine structure, and preparation method and application thereof | 桂林医学院 | 2024-11-15 | — | — | CN | disclosed |
| CN-117285504-A | Amino phenylacetamide derivative and preparation method and application thereof | 桂林医学院 | 2023-12-26 | — | — | CN | disclosed |
| US-20230348457-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL LTD (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-116863729-A | Multi-agent road traffic signal control method based on deep reinforcement learning algorithm | 大连交通大学 | 2023-10-10 | — | — | CN | disclosed |
| US-20230295151-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| US-11685735-B2 | Pharmaceutical composition comprising berberine salts for the treatment of various diseases or disorders | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD. (CN) | 2023-06-27 | — | — | US | disclosed |
| WO-2023030503-A1 | ANTI-ACVR2A ANTIBODIES AND USES THEREOF | LAEKNA THERAPEUTICS SHANGHAI CO., LTD. (CN) | 2023-03-09 | — | — | WO | disclosed |
| US-11422128-B2 | Immunoassay employing sulfated polysaccharide | LSI MEDIENCE CORPORATION (JP) | 2022-08-23 | — | — | US | disclosed |
| CN-113987969-A | Land-water dynamic simulation model of multi-elevation scale water flow network | 严大莲 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348457-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | CYP27A1, NR1H4, CYP7A1 | RRM1 2076/4885IDO1 1440/4885MEN1 2170/4885 |
| US-20250002490-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | CYP27A1, NR1H4, CYP7A1 | RRM1 2076/4885IDO1 1440/4885MEN1 2170/4885 |
| US-11685735-B2 | Pharmaceutical composition comprising berberine salts for the treatment of various diseases or disorders | CPT1B, CYP27A1, GLS2 | RRM1 2324/4885IDO1 1005/4885MEN1 1912/4885 |
| US-20230295151-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | CYP27A1, NR1H4, CYP7A1 | RRM1 2076/4885IDO1 1440/4885MEN1 2170/4885 |
| US-20240269313-A1 | CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A DRUG | PTH1R, SELPLG, CALCR | RRM1 663/4885IDO1 4840/4885MEN1 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.